ProQR Therapeutics Creating RNA therapies for patients in need

Decorative image

On a mission

At ProQR, we are passionate about pushing the boundaries of science and technology to create innovative solutions for unmet medical needs. Our team is dedicated to conducting cutting-edge research and development in the RNA editing field to improve the lives of patients and families affected by genetic disorders.

We believe that every person deserves access to the best possible care, and we are committed to working together as a community to make that happen. Join us on our mission to make a real difference in the lives of those we serve.

ProQRian in a company meeting

Our science

Latest press releases

Internal link More press releases
Female scientist working in the lab

ProQR Community News

  • “A new way of designing medicines”

    Community news

    The potential of this new technology for RNA therapeutics is immense, says Bart Klein, who was at the forefront of the Axiomer® technology development. ProQR’s Sr. Vice President Innovation makes his point about the promise of Axiomer® technology: “This opens up a whole new way of designing medicines for genetic diseases that were previously ‘out of reach’ for existing technologies.”

    A photo of Bart Klein

  • Exploring why companies partner their technology

    Community news

    Partnerships in our industry are very common as companies look to benefit from knowledge and resource sharing. In this blog we explore why companies, like ProQR, partner with other companies.

    Lenka in the Lab

ProQR & Eli Lilly and Company partnership

Since 2021 ProQR has partnered with Eli Lilly and Company focusing on the discovery, development, and commercialization of potential new using ProQR’s proprietary Axiomer® RNA editing platform.

Internal link Read about our partnership
ProQR and Lilly logos and Axiomer technology image